Culturally Tailored Nurse Coaching Study for Cancer Symptom Management
Utilizing a Culturally Tailored Nurse Coaching Intervention to Decrease Symptom Severity and Prevent Dehydration in Patients With Metastatic Cancer
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of the study is to see whether or not a telephone/ text message intervention, delivered by a registered nurse, is helpful in managing symptoms and can also prevent dehydration caused by chemotherapy treatment when given together for patients with metastatic breast, colon, lung or prostate cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2021
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedStudy Start
First participant enrolled
October 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedJune 2, 2023
May 1, 2023
1.6 years
April 30, 2021
May 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in MDASI scores
MD Anderson Symptom Inventory (MDASI) is a 19 item scale with a score range from 0-10 per symptom question that measures symptom severity plus symptom interference combined to measure total symptom burden. The higher score indicates worsening of symptoms.
baseline, up to 12 weeks
Incidents of dehydration
Incidents of unscheduled medical visits for IV hydration
up to 12 weeks
Secondary Outcomes (7)
change in Chronic Disease Self-Efficacy Scale (CDSES) scores
baseline, up to 12 weeks
change in Partners in Health Scale (PIHS) scores
baseline, up to 12 weeks
Percentage of completed call or text message
up to 12 weeks
Change in FACT-B Scores
baseline, up to 12 weeks
Change in FACT-P Scores
baseline, up to 12 weeks
- +2 more secondary outcomes
Study Arms (2)
CTNSM Group
EXPERIMENTALCulturally Tailored Nurse Symptom Management group (CTNSM) - participants in the CTNSM group will receive one in-person or telehealth face-to-face education session followed by a weekly telephone call and/or text message during the first 12 weeks of standard of care chemotherapy. In addition, participants can receive standard of care chemotherapy education.
Standard of Care (control) Group
ACTIVE COMPARATORParticipants in the control group will only be receiving the standard of care chemotherapy education.
Interventions
The Culturally Tailored Nurse-delivered telephone/text message symptom-management intervention (CTNSM) intervention is an in-person or telehealth face-to-face education session followed by a weekly telephone call and/or text message conducted for the first 12 weeks of standard of care chemotherapy .
Standard of Care chemotherapy education is a one-time patient education session about general treatment-related side effects patients can experience from chemotherapy and the interventions to mitigate the symptoms.
Eligibility Criteria
You may qualify if:
- Eligible for Chemotherapy for the first time (Previous \& Ongoing hormonal only treatment allowed OR Neoadjuvant \& Adjuvant chemotherapy regimens with 2+ drugs allowed)
- \> 18 years old
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
- There are no life expectancy restrictions
- Women of child-bearing potential are allowed in the study as long as they are eligible for the chemotherapy treatment.
- Ability to understand and the willingness to sign a written informed consent document.
You may not qualify if:
- Patients on immunotherapy only will be excluded
- Previous chemotherapy
- Under 18 years old
- Medically Diagnosed with a Cognitive Impairment. Rationale for excluding people with cognitive impairment is that they would not be able to fully participate in the self-management care aspects of the intervention via the telephone, nor provide informed consent.
- No access to a telephone
- Blind or Deaf; If subject is Hearing-impaired or illiterate, then the subject may have a family member participate as a telecommunication surrogate with them in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- Oncology Nursing Societycollaborator
Study Sites (1)
University of Miami Sylvester Comprehensive Cancer Ctr.
Miami, Florida, 33136, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natasha Solle, PhD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant research professor
Study Record Dates
First Submitted
April 30, 2021
First Posted
May 5, 2021
Study Start
October 27, 2021
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
June 2, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share